Publication | Closed Access

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

Cannabinoid Receptor 1Cannabis UseAlzheimer's DiseaseDementiaAmyloid DepositionNeuropharmacologyNeurochemical BiomarkersNeurologyNeuroscienceBrain PathologyMedicineMouse ModelCannabinoidsSocial SciencesLewy Body Dementia